1
|
Cucinotta D and Vanelli M: WHO declares
COVID-19 a pandemic. Acta Biomed. 91:157–160. 2020.PubMed/NCBI View Article : Google Scholar
|
2
|
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He
JX, Liu L, Shan H, Lei CL, Hui DSC, et al: China medical treatment
expert group for Covid-19. Clinical characteristics of coronavirus
disease 2019 in China. N Engl J Med. 382:1708–1720. 2020.PubMed/NCBI View Article : Google Scholar
|
3
|
Muñoz-Rodríguez JR, Gómez-Romero FJ,
Pérez-Ortiz JM, López-Juárez P, Santiago JL, Serrano-Oviedo L and
Redondo-Calvo FJ: COVID-19 SESCAM Network. Characteristics and risk
factors associated with mortality in a multicenter spanish cohort
of patients with COVID-19 pneumonia. Arch Bronconeumol. 57:34–41.
2021.PubMed/NCBI View Article : Google Scholar
|
4
|
Chiner-Vives E, Cordovilla-Pérez R, de la
Rosa-Carrillo D, García-Clemente M, Izquierdo-Alonso JL,
Otero-Candelera R, Pérez-de Llano L, Sellares-Torres J and de
Granda-Orive JI: Short and long-term impact of COVID-19 infection
on previous respiratory diseases. Arch Bronconeumol. 58 (Suppl
1):S39–S50. 2022.PubMed/NCBI View Article : Google Scholar : (In English,
Spanish).
|
5
|
Chlapoutakis S, Garmpi A, Trakas N,
Damaskos C and Georgakopoulou VE: Recurrent exacerbations of
chronic obstructive pulmonary disease reveal Swyer-James-Macleod
syndrome in a 63-year-old patient. Cureus.
13(e12601)2021.PubMed/NCBI View Article : Google Scholar
|
6
|
Behrendt A and Lee Y: Swyer-james-macleod
syndrome. In: StatPearls [Internet]. StatPearls Publishing,
Treasure Island, FL, 2022.
|
7
|
Chang AB, Masel JP and Masters B:
Post-infectious bronchiolitis obliterans: Clinical, radiological
and pulmonary function sequelae. Pediatr Radiol. 28:23–29.
1998.PubMed/NCBI View Article : Google Scholar
|
8
|
Tortajada M, Gracia M, García E and
Hernández R: Diagnostic considerations in unilateral hyperlucency
of the lung (Swyer-James-MacLeod Syndrome). Allergol Immunopathol
(Madr). 32:265–270. 2004.PubMed/NCBI View Article : Google Scholar : (In Spanish).
|
9
|
Wang JY, Chen KY, Chang YC, Chang YL and
Lee LN: Swyer-James syndrome complicated by lung abscess. J Formos
Med Assoc. 99:252–256. 2000.PubMed/NCBI
|
10
|
Soni R and Barnes D: Macleod's syndrome
presenting with spontaneous pneumothorax. Respirology. 4:275–277.
1999.PubMed/NCBI View Article : Google Scholar
|
11
|
National Institutes of Health: COVID-19
Treatment Guidelines. Therapeutic Management of Hospitalized Adults
With COVID-19. https://www.covid19treatmentguidelines.nih.gov/tables/therapeutic-management-of-hospitalized-adults/.
Accessed July 19, 2022.
|
12
|
Graziani D, Soriano JB, Rio-Bermudez CD,
Morena D, Díaz T, Castillo M, Alonso M, Ancochea J, Lumbreras S and
Izquierdo JL: Characteristics and prognosis of COVID-19 in patients
with COPD. J Clin Med. 9(3259)2020.PubMed/NCBI View Article : Google Scholar
|
13
|
Lippi G and Henry BM: Chronic obstructive
pulmonary disease is associated with severe coronavirus disease
2019 (COVID-19). Respir Med. 167(105941)2020.PubMed/NCBI View Article : Google Scholar
|
14
|
Quaranta VN, Kyriakopoulos C, Liontos A,
Barkas F, Chronis C, Biros D, Athanasiou L, Milionis O, Tsourlos S,
Veliani C, et al: Baseline characteristics and outcome predictors
in patients hospitalized with COVID-19 in the university general
hospital of Ioannina, Greece. Pneumon. 35(9)2022.
|
15
|
Liu S, Cao Y, Du T and Zhi Y: Prevalence
of comorbid asthma and related outcomes in COVID-19: A systematic
review and meta-analysis. J Allergy Clin Immunol Pract. 9:693–701.
2021.PubMed/NCBI View Article : Google Scholar
|
16
|
Shi T, Pan J, Vasileiou E, Robertson C and
Sheikh A: Public Health Scotland and the EAVE II Collaborators.
Risk of serious COVID-19 outcomes among adults with asthma in
Scotland: A national incident cohort study. Lancet Respir Med.
10:347–354. 2022.PubMed/NCBI View Article : Google Scholar
|
17
|
Georgakopoulou VE, Avramopoulos P,
Papalexis P, Bitsani A, Damaskos C, Garmpi A, Gkoufa A, Garmpis N,
Mantzouranis K, Chlapoutakis S, et al: Exacerbation of
bronchiectasis by Pseudomonas putida complicating COVID-19 disease:
A case report. Exp Ther Med. 22(1452)2021.PubMed/NCBI View Article : Google Scholar
|
18
|
Choi H, Lee H, Lee SK, Yang B, Chung SJ,
Yeo Y, Park TS, Park DW, Moon JY, Kim TH, et al: Impact of
bronchiectasis on susceptibility to and severity of COVID-19: A
nationwide cohort study. Ther Adv Respir Dis.
15(1753466621995043)2021.PubMed/NCBI View Article : Google Scholar
|
19
|
Guan WJ, Liang WH, Shi Y, Gan LX, Wang HB,
He JX and Zhong NS: Chronic respiratory diseases and the outcomes
of COVID-19: A nationwide retrospective cohort study of 39,420
cases. J Allergy Clin Immunol Pract. 9:2645–2655. 2021.PubMed/NCBI View Article : Google Scholar
|
20
|
Aveyard P, Gao M, Lindson N,
Hartmann-Boyce J, Watkinson P, Young D, Coupland CAC, Tan PS, Clift
AK, Harrison D, et al: Association between pre-existing respiratory
disease and its treatment, and severe COVID-19: A population cohort
study. Lancet Respir Med. 9:909–923. 2021.PubMed/NCBI View Article : Google Scholar
|
21
|
Crichton ML, Shoemark A and Chalmers JD:
The impact of the COVID-19 pandemic on exacerbations and symptoms
in bronchiectasis: A prospective study. Am J Respir Crit Care Med.
204:857–859. 2021.PubMed/NCBI View Article : Google Scholar
|
22
|
Griffin JB, Haddix M, Danza P, Fisher R,
Koo TH, Traub E, Gounder P, Jarashow C and Balter S: SARS-CoV-2
infections and hospitalizations among persons aged ≥16 years, by
vaccination status-Los Angeles County, California, May 1-July 25,
2021. MMWR Morb Mortal Wkly Rep. 70:1170–1176. 2021.PubMed/NCBI View Article : Google Scholar
|
23
|
Southworth T, Jackson N and Singh D:
Airway immune responses to COVID-19 vaccination in COPD patients
and healthy subjects. Eur Respir J. 60(2200497)2022.PubMed/NCBI View Article : Google Scholar
|